Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Differential role of sodium channels SCN1A and SCN2A gene polymorphisms with epilepsy and multiple drug resistance in the north Indian population.

Lakhan R, Kumari R, Misra UK, Kalita J, Pradhan S, Mittal B.

Br J Clin Pharmacol. 2009 Aug;68(2):214-20. doi: 10.1111/j.1365-2125.2009.03437.x.

2.

Multidrug resistance in epilepsy and polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, and SCN3A: correlation among phenotype, genotype, and mRNA expression.

Kwan P, Poon WS, Ng HK, Kang DE, Wong V, Ng PW, Lui CH, Sin NC, Wong KS, Baum L.

Pharmacogenet Genomics. 2008 Nov;18(11):989-98. doi: 10.1097/FPC.0b013e3283117d67.

PMID:
18784617
3.

No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population.

Lakhan R, Misra UK, Kalita J, Pradhan S, Gogtay NJ, Singh MK, Mittal B.

Epilepsy Behav. 2009 Jan;14(1):78-82. doi: 10.1016/j.yebeh.2008.08.019. Epub 2008 Oct 8.

PMID:
18812236
4.

SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis.

Haerian BS, Baum L, Kwan P, Tan HJ, Raymond AA, Mohamed Z.

Pharmacogenomics. 2013 Jul;14(10):1153-66. doi: 10.2217/pgs.13.104.

PMID:
23859570
5.

Association of intronic polymorphism rs3773364 A>G in synapsin-2 gene with idiopathic epilepsy.

Lakhan R, Kalita J, Misra UK, Kumari R, Mittal B.

Synapse. 2010 May;64(5):403-8. doi: 10.1002/syn.20740.

PMID:
20034013
6.

Pharmacogenomic association study on the role of drug metabolizing, drug transporters and drug target gene polymorphisms in drug-resistant epilepsy in a north Indian population.

Kumari R, Lakhan R, Garg RK, Kalita J, Misra UK, Mittal B.

Indian J Hum Genet. 2011 May;17 Suppl 1:S32-40. doi: 10.4103/0971-6866.80357.

7.

Association between SCN1A polymorphism and carbamazepine-resistant epilepsy.

Abe T, Seo T, Ishitsu T, Nakagawa T, Hori M, Nakagawa K.

Br J Clin Pharmacol. 2008 Aug;66(2):304-7. doi: 10.1111/j.1365-2125.2008.03203.x. Epub 2008 Apr 11.

8.

Predisposition to epilepsy--does the ABCB1 gene play a role?

Nurmohamed L, Garcia-Bournissen F, Buono RJ, Shannon MW, Finkelstein Y.

Epilepsia. 2010 Sep;51(9):1882-5. doi: 10.1111/j.1528-1167.2010.02588.x. Review.

9.

Gene-to-gene interaction between sodium channel-related genes in determining the risk of antiepileptic drug resistance.

Jang SY, Kim MK, Lee KR, Park MS, Kim BC, Cho KH, Lee MC, Kim YS.

J Korean Med Sci. 2009 Feb;24(1):62-8. doi: 10.3346/jkms.2009.24.1.62. Epub 2009 Feb 28.

10.

Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1.

Siddiqui A, Kerb R, Weale ME, Brinkmann U, Smith A, Goldstein DB, Wood NW, Sisodiya SM.

N Engl J Med. 2003 Apr 10;348(15):1442-8.

11.

Failure to detect association between polymorphisms of the sodium channel gene SCN1A and febrile seizures in Chinese patients with epilepsy.

Zhang C, Wong V, Ng PW, Lui CH, Sin NC, Wong KS, Baum L, Kwan P.

Epilepsia. 2010 Sep;51(9):1878-81. doi: 10.1111/j.1528-1167.2010.02587.x.

12.

Case-control association study of polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, SCN3A, SCN1B, and SCN2B and epilepsy.

Baum L, Haerian BS, Ng HK, Wong VC, Ng PW, Lui CH, Sin NC, Zhang C, Tomlinson B, Wong GW, Tan HJ, Raymond AA, Mohamed Z, Kwan P.

Hum Genet. 2014 May;133(5):651-9. doi: 10.1007/s00439-013-1405-1. Epub 2013 Dec 13.

PMID:
24337656
13.

Effects of EPHX1, SCN1A and CYP3A4 genetic polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy.

Yun W, Zhang F, Hu C, Luo X, Xue P, Wang J, Ge Y, Meng H, Guo Y.

Epilepsy Res. 2013 Dec;107(3):231-7. doi: 10.1016/j.eplepsyres.2013.09.011. Epub 2013 Sep 30.

PMID:
24125961
14.
15.

Multidrug resistance 1 (MDR1) gene polymorphisms in childhood drug-resistant epilepsy.

Alpman A, Ozkinay F, Tekgul H, Gokben S, Pehlivan S, Schalling M, Ozkinay C.

J Child Neurol. 2010 Dec;25(12):1485-90. doi: 10.1177/0883073810368997. Epub 2010 May 6.

PMID:
20448249
16.

A functional polymorphism in the SCN1A gene is not associated with carbamazepine dosages in Austrian patients with epilepsy.

Zimprich F, Stogmann E, Bonelli S, Baumgartner C, Mueller JC, Meitinger T, Zimprich A, Strom TM.

Epilepsia. 2008 Jun;49(6):1108-9. doi: 10.1111/j.1528-1167.2008.01549_4.x. No abstract available.

17.

SCN1AIVS5-91G>A polymorphism is associated with susceptibility to epilepsy but not with drug responsiveness.

Kumari R, Lakhan R, Kumar S, Garg RK, Misra UK, Kalita J, Mittal B.

Biochimie. 2013 Jun;95(6):1350-3. doi: 10.1016/j.biochi.2013.02.006. Epub 2013 Mar 1.

PMID:
23466530
18.

Cryptogenic epileptic syndromes related to SCN1A: twelve novel mutations identified.

Zucca C, Redaelli F, Epifanio R, Zanotta N, Romeo A, Lodi M, Veggiotti P, Airoldi G, Panzeri C, Romaniello R, De Polo G, Bonanni P, Cardinali S, Baschirotto C, Martorell L, Borgatti R, Bresolin N, Bassi MT.

Arch Neurol. 2008 Apr;65(4):489-94. doi: 10.1001/archneur.65.4.489.

PMID:
18413471
19.

Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy.

Ma CL, Wu XY, Zheng J, Wu ZY, Hong Z, Zhong MK.

Pharmacogenomics. 2014 Jul;15(10):1323-36. doi: 10.2217/pgs.14.89.

PMID:
25155934
20.

ABCB1, ABCC2, SCN1A, SCN2A, GABRA1 gene polymorphisms and drug resistant epilepsy in the Chinese Han population.

Zhou L, Cao Y, Long H, Long L, Xu L, Liu Z, Zhang Y, Xiao B.

Pharmazie. 2015 Jun;70(6):416-20.

PMID:
26189305

Supplemental Content

Support Center